BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20062539)

  • 1. TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.
    Lluis JM; Nachbur U; Cook WD; Gentle IE; Moujalled D; Moulin M; Wong WW; Khan N; Chau D; Callus BA; Vince JE; Silke J; Vaux DL
    PLoS One; 2010 Jan; 5(1):e8620. PubMed ID: 20062539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
    Diessenbacher P; Hupe M; Sprick MR; Kerstan A; Geserick P; Haas TL; Wachter T; Neumann M; Walczak H; Silke J; Leverkus M
    J Invest Dermatol; 2008 May; 128(5):1134-47. PubMed ID: 17989734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression.
    Liang DY; Huang W; Chang Q; Hou YQ
    PLoS One; 2018; 13(2):e0191545. PubMed ID: 29444104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells.
    Huang HL; Yeh WC; Lai MZ; Mirtsos C; Chau H; Chou CH; Benchimol S
    Br J Cancer; 2009 Nov; 101(9):1555-64. PubMed ID: 19826422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade.
    Choo MK; Kawasaki N; Singhirunnusorn P; Koizumi K; Sato S; Akira S; Saiki I; Sakurai H
    Mol Cancer Ther; 2006 Dec; 5(12):2970-6. PubMed ID: 17172402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes.
    Wachter T; Sprick M; Hausmann D; Kerstan A; McPherson K; Stassi G; Bröcker EB; Walczak H; Leverkus M
    J Biol Chem; 2004 Dec; 279(51):52824-34. PubMed ID: 15459191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it.
    Moujalled DM; Cook WD; Lluis JM; Khan NR; Ahmed AU; Callus BA; Vaux DL
    Cell Death Differ; 2012 May; 19(5):808-15. PubMed ID: 22095280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
    Zhang L; Blackwell K; Workman LM; Chen S; Pope MR; Janz S; Habelhah H
    Mol Cell Biol; 2015 Oct; 35(19):3324-38. PubMed ID: 26195820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kurarinone promotes TRAIL-induced apoptosis by inhibiting NF-κB-dependent cFLIP expression in HeLa cells.
    Seo OW; Kim JH; Lee KS; Lee KS; Kim JH; Won MH; Ha KS; Kwon YG; Kim YM
    Exp Mol Med; 2012 Nov; 44(11):653-64. PubMed ID: 22932446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
    Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
    Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways.
    Hu WH; Johnson H; Shu HB
    J Biol Chem; 1999 Oct; 274(43):30603-10. PubMed ID: 10521444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP.
    Morioka S; Omori E; Kajino T; Kajino-Sakamoto R; Matsumoto K; Ninomiya-Tsuji J
    Oncogene; 2009 Jun; 28(23):2257-65. PubMed ID: 19421137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis.
    Ranjan K; Pathak C
    Sci Rep; 2016 Mar; 6():22787. PubMed ID: 26972597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
    Qin JZ; Bacon P; Chaturvedi V; Nickoloff BJ
    J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRADD is critical for resistance to TRAIL-induced cell death through NF-κB activation.
    Kim JY; Lee JY; Kim DG; Koo GB; Yu JW; Kim YS
    FEBS Lett; 2011 Jul; 585(14):2144-50. PubMed ID: 21627969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cFLIP
    Davidovich P; Higgins CA; Najda Z; Longley DB; Martin SJ
    Cell Rep; 2023 Dec; 42(12):113476. PubMed ID: 37988267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR8-mediated NF-kappaB and JNK activation are TAK1-independent and MEKK3-dependent.
    Qin J; Yao J; Cui G; Xiao H; Kim TW; Fraczek J; Wightman P; Sato S; Akira S; Puel A; Casanova JL; Su B; Li X
    J Biol Chem; 2006 Jul; 281(30):21013-21021. PubMed ID: 16737960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death.
    Thomas RP; Farrow BJ; Kim S; May MJ; Hellmich MR; Evers BM
    Surgery; 2002 Aug; 132(2):127-34. PubMed ID: 12219002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
    Shim JH; Xiao C; Paschal AE; Bailey ST; Rao P; Hayden MS; Lee KY; Bussey C; Steckel M; Tanaka N; Yamada G; Akira S; Matsumoto K; Ghosh S
    Genes Dev; 2005 Nov; 19(22):2668-81. PubMed ID: 16260493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.